Secondary Release of Exosomes from Astrocytes Contributes to the Increase in Neural Plasticity and Improvement of Functional Recovery after Stroke in Rats Treated with Exosomes Harvested from MicroRNA 133b-Overexpressing Multipotent Mesenchymal Stromal Cells

Cited by papers we hold 11

• Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies · 2025
  Corrected
• Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities · 2021
  No notice
• Neurovascular Unit: A critical role in ischemic stroke · 2021
  No notice
• Current Knowledge and Future Perspectives on Mesenchymal Stem Cell-Derived Exosomes as a New Therapeutic Agent · 2020
  No notice
• The Role of Exosomal microRNAs and Oxidative Stress in Neurodegenerative Diseases · 2020
  No notice
• MSC-Derived Exosomes-Based Therapy for Peripheral Nerve Injury: A Novel Therapeutic Strategy · 2019
  No notice
• Recent advances and challenges in the recovery and purification of cellular exosomes · 2019
  No notice
• Potential Effects of MSC-Derived Exosomes in Neuroplasticity in Alzheimer’s Disease · 2018
  No notice
• Exosomes, an Unmasked Culprit in Neurodegenerative Diseases · 2017
  No notice
• Human Neural Stem Cell Extracellular Vesicles Improve Tissue and Functional Recovery in the Murine Thromboembolic Stroke Model · 2017
  No notice
• Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles and Their Potential as Novel Immunomodulatory Therapeutic Agents · 2017
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.